Article Figures & Data
Figures
- Figure 1.
Primary Endpoint: Cardiovascular Mortality/Hospitalization for Worsening HF.
Reproduced from The Lancet, Volume 376, Issue 9744, Swedberg K, Komajda M, Bohm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Copyright 2010, with permission from Elsevier.
- Figure 2.
Mean Heart Rate Reduction.
Reproduced from The Lancet, Volume 376, Issue 9744, Swedberg K, Komajda M, Bohm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Copyright 2010, with permission from Elsevier.
Tools
Ivabradine Added to Standard Therapy Improves Outcomes in Patients with Systolic HF
Permalink:
